MedTrace Logo

Evaluation of the Body Slimming Effect of TCI904

NCT05805488 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2023-04-10

No results posted yet for this study

Summary

To assess the efficacy of Lactobacillus delbrueckii ssp. bulgaricus TCI904 on body slimming

Conditions

  • Body Weight
  • Metabolic Syndrome

Interventions

DIETARY_SUPPLEMENT

Placebo sachet

consume 1 sachet per day

DIETARY_SUPPLEMENT

TCI904 sachet

consume 1 sachet per day

Sponsors & Collaborators

  • TCI Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Yang-Chang Wu · China Medical University, China

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-10-01
Primary Completion
2022-01-31
Completion
2022-12-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05805488 on ClinicalTrials.gov